Abstract
Dementia affects more than 36 million people worldwide. As a major cause of late-life functional dependence, institutionalization, poor quality of life, and mortality, dementia has posed a tremendous threat to public health and healthcare systems in both high- and middle-income countries. Preventing or postponing the onset of dementia by targeting major modifiable risk factors will significantly reduce the individual and societal burden of the disease. Dementia is a multifactorial disorder, in which the risk of dementia is determined by biological/genetic factors, environmental factors, and their interactions experienced over the lifespan. In the last two decades, a growing body of evidence from multidisciplinary research has suggested that lifestyle and metabolic risk factors (e.g., smoking, excessive alcohol consumption, physical inactivity, obesity, hypertension, diabetes, and hyperlipidemia) are involved in the development and progression of dementia. In particular, from a life course perspective, systematic reviews and meta-analyses of prospective studies have revealed the age-dependent association of dementia with major metabolic factors such as hypertension, obesity, and high cholesterol, i.e., possessing these factors in midlife, but not necessarily in late life, is associated with increased risk of dementia. The biological plausibility for lifestyle or metabolic risk factors to be involved in the pathogenesis and clinical expression of dementia is partly supported by neuroimaging and neuropathological studies. This has significant implications for developing intervention strategies against dementia, i.e., the multifactorial nature of dementia and the proper time-window over the lifespan for intervention should be taken into account in the future when designing preventative programs against this devastating disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ancelin ML, Carrière I, Barberger-Gateau P et al (2012) Lipid lowering agents, cognitive decline, and dementia: the Three-City Study. J Alzheimers Dis 30:629–637
Anstey KJ, von Sanden C, Salim A, O’Kearney R (2007) Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 166:367–378
Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16:343–354
Anstey KJ, Mack HA, Cherbuin N (2009) Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 17:542–555
Anstey KJ, Cherbuin N, Budge M, Young J (2011) Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 12:e426–e437
Arvanitakis Z, Leurgans SE, Barnes LL et al (2011) Microinfarct pathology, dementia, and cognitive systems. Stroke 42:722–727
Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 10:819–828
Barnes DE, Covinsky K, Whitmer RA et al (2009) Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology 73:173–179
Beydoun MA, Beydoun HA, Wang Y (2008) Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 9: 204–218
Bowen ME (2012) A prospective examination of the relationship between physical activity and dementia risk in later life. Am J Health Promot 26:333–340
Brodaty H, Breteler MM, Dekosky ST et al (2011) The world of dementia beyond 2020. J Am Geriatr Soc 59:923–927
Buchman AS, Boyle PA, Yu L et al (2012) Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 78:1323–1329
Casserly I, Topol E (2004) Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139–1146
Cataldo JK, Prochaska JJ, Glantz SA (2010) Cigarette smoking is a risk factor for Alzheimer’s disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 19:465–480
Chan KY, Wang W, Wu JJ et al (2013) Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 381:2016–2023
Chen R (2012) Association of environmental tobacco smoke with dementia and Alzheimer’s disease among never smokers. Alzheimers Dement 8:590–595
Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42:484–491
Crane PK, Walker R, Hubbard RA (2013) Glucose levels and risk of dementia. N Engl J Med 369:540–548
Dahl Aslan A (2014) Obesity, cognitive ageing, and dementia: the usefulness of longitudinal studies to understand the obesity paradox. In: Leist AK, Kulmala J (eds) Health and cognition in old age. Springer, New York
Debette S, Seshadri S, Beiser A et al (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77:461–468
Dolan H, Crain B, Troncoso J et al (2010) Atherosclerosis, dementia, and Alzheimer’s disease in the BLSA cohort. Ann Neurol 68:231–240
Duron E, Hanon O (2010) Antihypertensive treatments, cognitive decline, and dementia. J Alzheimers Dis 20:903–914
Exalto LG, Quesenberry CP, Barnes D et al (2013) Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement. pii: S1552-5260(13)02465-5
Feldman HH, Doody RS, Kivipelto M et al (2010) Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 74:956–964
Fitzpatrick AL, Kuller LH, Lopez OL et al (2009) Midlife and late-life obesity and the risk of dementia: the Cardiovascular Health Study. Arch Neurol 66:336–342
Forti P, Pisacane N, Rietti E et al (2010) Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58:487–492
Fratiglioni L, Qiu C (2013) Epidemiology of dementia. In: Dening T, Thomas A (eds) The Oxford textbook of old age psychiatry, 5th edn. Oxford University Press, New York, pp 389–413
Garcia-Alloza M, Gregory J, Kuchibhotla KV et al (2011) Cerebrovascular lesions induce transient β-amyloid deposition. Brain 134:3697–3707
Gelber RP, Petrovitch H, Masaki KH et al (2012) Lifestyle and the risk of dementia in Japanese-American men. J Am Geriatr Soc 60:118–123
Gelber RP, Ross GW, Petrovitch H et al (2013) Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia Aging Study. Neurology 81:888–895
Guan JW, Huang CQ, Li YH et al (2011) No association between hypertension and risk for Alzheimer’s disease: a meta-analysis of longitudinal studies. J Alzheimers Dis 27:799–807
Haag MD, Hofman A, Koudstaal PJ et al (2009) Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology 72:1727–1734
Hafsteinsdottir SH, Eiriksdottir G, Sigurdsson S et al (2012) Brain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik Study. Neurobiol Aging 33:829.e1-8
Hamer M, Chida Y (2009) Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 39:3–11
Herghelegiu AM, Prada GI (2014) Impact of metabolic control on cognitive function and health-related quality of life in older diabetics. In: Leist AK, Kulmala J (eds) Health and cognition in old age. Springer, New York
Hoffman LB, Schmeidler J, Lesser GT et al (2009) Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology 72:1720–1726
Jagger C, McKee M, Christensen K et al (2013) Mind the gap–reaching the European target of a 2-year increase in healthy life years in the next decade. Eur J Public Health 23:829–833
Kalaria RN (2009) Neurodegenerative disease: diabetes, microvascular pathology and Alzheimer disease. Nat Rev Neurol 5:305–306
Kopf D, Frölich L (2009) Risk of incident Alzheimer’s disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 16:677–685
Launer LJ, Hughes T, Yu B et al (2010) Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension 55:1352–1359
Launer LJ, Hughes TM, White LR (2011) Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 70:774–780
Levi Marpillat N, Macquin-Mavier I, Tropeano AI et al (2013) Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens 31:1073–1082
Li NC, Lee A, Whitmer RA et al (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340:b5465
Lin CH, Sheu WH (2013) Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 273:102–110
Loef M, Walach H (2013) Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity (Silver Spring) 21:E51–E55
Lu FP, Lin KP, Kuo HK (2009) Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 4:e4144
Matsuzaki T, Sasaki K, Tanizaki Y et al (2010) Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 75:764–770
Mayeda ER, Haan MN, Kanaya AM et al (2013) Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care 36:2600–2606
McGuinness B, Craig D, Bullock R, Passmore P (2009a) Statins for the prevention of dementia. Cochrane Database Syst Rev (2):CD003160
McGuinness B, Todd S, Passmore P, Bullock R (2009b) Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev (4):CD004034
McGuinness B, O’Hare J, Craig D et al (2013) Cochrane review on ‘Statins for the treatment of dementia’. Int J Geriatr Psychiatry 28:119–126
Morgan GS, Gallacher J, Bayer A et al (2012) Physical activity in middle-age and dementia in later life: findings from a prospective cohort of men in Caerphilly, South Wales and a meta-analysis. J Alzheimers Dis 31:569–580
Norton MC, Dew J, Smith H et al (2012) Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer’s disease: the Cache County study. J Am Geriatr Soc 60:405–412
Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701
Peters R, Beckett N, Forette F et al (2008a) Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 7:683–689
Peters R, Peters J, Warner J et al (2008b) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37:505–512
Peters R, Poulter R, Warner J et al (2008c) Smoking, dementia and cognitive decline in the elderly: a systematic review. BMC Geriatr 8:36
Power MC, Weuve J, Gagne JJ et al (2011) The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology 22:646–659
Prince M, Acosta D, Ferri CP et al (2012) Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study. Lancet 380:50–58
Prince M, Bryce R, Albanese E et al (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63–75
Profenno LA, Porsteinsson AP, Faraone SV (2010) Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67:505–512
Qiu C (2011) Epidemiological findings of vascular risk factors in Alzheimer’s disease: implications for therapeutic and preventive intervention. Expert Rev Neurother 11:1593–1607
Qiu C (2012) Preventing Alzheimer’s disease by targeting vascular risk factors: hope and gap. J Alzheimers Dis 32:721–731
Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487–499
Qiu C, Cotch MF, Sigurdsson S et al (2010a) Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 75:2221–2228
Qiu C, Sigurdsson S, Zhang Q, et al (2014) Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol 75:138–146
Qiu C, Xu W, Fratiglioni L (2010b) Vascular and psychosocial factors for Alzheimer’s disease: epidemiological evidence toward intervention. J Alzheimers Dis 20:689–697
Raffaitin C, Gin H, Empana JP et al (2009) Metabolic syndrome and risk for incident Alzheimer’s disease or vascular dementia: the Three-City Study. Diabetes Care 32:169–174
Reijmer YD, Leemans A, Brundel M et al (2013) Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 62:2112–2115
Reitz C, Tang MX, Schupf N et al (2010) A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol 67:835–841
Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137–152
Robine JM, Cambois E, Nusselder W et al (2013) The joint action on healthy life years (JA: EHLEIS). Arch Public Health 71:2
Rusanen M, Kivipelto M, Quesenberry CP Jr et al (2011) Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 171:333–339
Sano M, Bell KL, Galasko D et al (2011) A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 77:556–563
Scarmeas N, Luchsinger JA, Schupf N et al (2009) Physical activity, diet, and risk of Alzheimer disease. JAMA 302:627–637
Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197–2204
Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 68:1385–1392
Smith EE, Schneider JA, Wardlaw JM, Greenberg SM (2012) Cerebral microinfarcts: the invisible lesions. Lancet Neurol 11:272–282
Staessen JA, Thijs L, Richart T et al (2011) Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 57:e6–e7
Stephan BCM (2014) Models for predicting risk of dementia: predictive accuracy and model complexity. In: Leist AK, Kulmala J (eds) Health and cognition in old age. Springer, New York
Strozyk D, Dickson DW, Lipton RB et al (2010) Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging 31:1710–1720
Tolppanen AM, Lavikainen P, Solomon A et al (2013) History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. Diabetes Care 36:2015–2019
Vagelatos NT, Eslick GD (2013) Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 35:152–160
van Elderen SG, de Roos A, de Craen A et al (2010) Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75:997–1002
Viswanathan A, Rocca WA, Tzourio C (2009) Vascular risk factors and dementia: how to move forward? Neurology 72:368–374
Wharton SB, Brayne C, Savva GM et al (2011) Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience. J Alzheimers Dis 25:359–372
Whitmer RA, Karter AJ, Yaffe K et al (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572
Wimo A, Jönsson L, Bond J et al (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 9:1–11.e3
Wong WB, Lin VW, Boudreau D, Devine EB (2013) Statins in the prevention of dementia and Alzheimer’s disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol Drug Saf 22:345–358
Xu W, Qiu C, Gatz M et al (2009) Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58:71–77
Yaffe K, Falvey CM, Hamilton N et al (2013) Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173:1300–1306
Yasar S, Xia J, Yao W et al (2013) Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology 81:896–903
Acknowledgments
This work was supported by the European Program Future Leaders of Ageing Research in Europe (FLARE), coordinated by the European Research Area in Ageing (ERA-AGE). Dr. C. Qiu was supported in part by the Swedish Council for Working Life and Social Research (FAS), Swedish Research Council (VR), Swedish Brain Power, and Karolinska Institute, Stockholm, Sweden. I would like to thank Dr. Yajun Liang for providing thoughtful comments on this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Qiu, C. (2014). Lifestyle Factors in the Prevention of Dementia: A Life Course Perspective. In: Leist, A., Kulmala, J., Nyqvist, F. (eds) Health and Cognition in Old Age. International Perspectives on Aging, vol 10. Springer, Cham. https://doi.org/10.1007/978-3-319-06650-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-06650-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06649-3
Online ISBN: 978-3-319-06650-9
eBook Packages: Humanities, Social Sciences and LawSocial Sciences (R0)